🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multi-center, double-blind, placebo-controlled, Phase I stu...
Status
Completed
Location
University of Iowa - Vaccine Research and Education Unit
Start Date
2016-07-05
Trial ID
NCT02743455
Treatments Being Tested
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
"Multimeric-001" (M-001) has been recently developed, containing conserved,...
Status
Completed
Location
Hadassah medical center
Start Date
2011-08
Trial ID
NCT01419925
This study intends to test the hypothesis that the malaria antigen PfPEBS, ...
Status
Unknown
Location
Centre Hospitalier Universitaire Vaudois (CHUV)
Start Date
2012-05
Trial ID
NCT01605786
This study is designed to 1) describe the safety, tolerability, and immunog...
Status
Completed
Location
Bliss Healthcare Services ( Site 0010)
Start Date
2018-07-06
Trial ID
NCT03480802
Treatments Being Tested
LA rVSVΔG-ZEBOV-GP -02-PED is a Phase 1/2, randomized, controlled open labe...
Status
Completed
Location
Centre de Recherches Médicales de Lambaréné
Start Date
2021-04-09
Trial ID
NCT05130398
This Phase 2, randomized, observer-blind, dose-confirmation clinical study ...
Status
Completed
Location
AMR Tempe
Start Date
2022-08-25
Trial ID
NCT05501561
Treatments Being Tested
Influenza is an acute respiratory disease caused by influenza viruses. Ther...
Status
Completed
Location
Guanyun County Center for Disease Control and Prevention
Start Date
2016-01
Trial ID
NCT02710409
Treatments Being Tested
This is Phase I, randomized, open-label, active-controlled study to evaluat...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-02-05
Trial ID
NCT06800131
This is a phase 3, randomized, double-blind, active comparator-controlled s...
Status
Completed
Location
Central Research Associates ( Site 0067)
Start Date
2022-07-13
Trial ID
NCT05425732